HOME
市場調査レポート
分子診断の世界市場：2026年に至る技術別、用途別予測
Molecular Diagnostics Market by Product & Service(Reagents, Kits, PoC & Tabletop Instruments), Application(COVID-19, Hepatitis, HAI, HIV, Oncology, Genetic Tests), Technology (PCR, NGS, ISH), End User (Hospitals, Diagnostic Labs)-Global Forecast to 2026
- 出版元：MarketsandMarkets
出版元について - 発行年：2021年4月
- 定価 Single User License(1名様ライセンス)US$4,950(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文265ページになります。
- 商品コード：MAM2403
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
分子診断の世界市場規模は2021年で推計178億ドル、この先2026年には318億ドルに達すると予測されます。レポート分子診断の世界市場について2026年までの市場予測データ(金額US$)を掲載しています。また市場をさまざまな切り口で細分化し、そのセグメント市場ごとの市場予測を中心に構成されています。当レポートでの各種セグメント市場の区分は、製品/サービス別市場、技術別市場、用途別市場、エンドユーザー別市場および主要国地域別市場、などとなっています。また競合状況、主要企業情報（14社）、市場ダイナミクス、COVID-19影響診断、市場シェア分析などの分析情報も加味し、分子診断市場の今後成長性および動向を詳細にレポートしています。
【レポート構成概要】 
◆分子診断の世界市場予測2019-2026年
・市場規模(US$)
◆製品/サービス別、市場-2026年
試薬/キット
機器
・卓上機器
・ポータブル/POC機器
サービス/ソフトウェア
※(市場規模US$)
◆技術別、市場-2026年
・ポリメラーゼ連鎖反応（PCR）
・等温核酸増幅技術（INAAT）
・DNAシーケンシングと次世代シーケンシング
・In situ ハイブリダイゼーション(ISH)
・DNAマイクロアレイ
・その他技術
※(市場規模US$)
◆用途別、市場-2026年
感染症診断
・COVID-19
・肝炎
・CT / NG
・HIV
・HAI
・HPV
・結核
・インフルエンザ
・その他感染症
腫瘍学検査
・乳がん
・大腸がん
・肺がん
・前立腺がん
・その他がん
遺伝子検査
その他用途
※(市場規模US$)
※感染症診断各種は、検査回数データMillion Test掲載)
◆エンドユーザー別、市場-2026年
・診断機関
・病院/クリニック
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2026年
北米
・米国、カナダ
欧州
・ドイツ、イタリア、フランス
・ロシア、スペイン、英国
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※地域別に全セグメントの細分化データ掲載
※国別に各種セグメントの細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス分析（ドライバー、障壁、機会、課題）
・COVID-19影響診断
・価格分析
・バリューチェーン分析
・サプライチェーン分析
・エコシステム分析
・ファイブフォース分析
・PESTLE分析
・規制状況
・貿易分析
・技術分析
・市場シェア分析
・競合状況
◆分子診断の主要企業プロフィール動向
・F. HOFFMANN-LA ROCHE LTD.
・HOLOGIC, INC.
・BIOMÉRIEUX SA
・ABBOTT LABORATORIES
・QIAGEN
・THERMO FISHER SCIENTIFIC INC.
・ILLUMINA, INC.
・MYRIAD GENETICS INC.
・SIEMENS HEALTHINEERS AG
・DANAHER CORPORATION
・GRIFOLS S.A.
・AGILENT TECHNOLOGIES INC.
・BECTON, DICKINSON AND COMPANY
・DIASORIN S.P.A
(その他企業)
・QUIDEL CORPORATION
・GENETIC SIGNATURES
・MDX HEALTH
・EXACT SCIENCES
・BIOCARTIS NV
・TBG DIAGNOSTICS LTD.
・GENMARK DIAGNOSTICS INC.
・LUMINEX CORPORATION
・HTG MOLECULAR DIAGNOSTICS
・VELA DIAGNOSTICS
・AMOY DIAGNOSTICS CO. LTD.
・MOLBIO DIAGNOSTICS PVT. LTD
・S PVT. LTD.: BUSINESS OVERVIEW
・ELITECHGROUP
・SAVYON DIAGNOSTICS LTD.
・ABACUS DIAGNOSTICA OY
・GENEOMBIO TECHNOLOGIES PVT LTD.
（全265頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
英文詳細目次(table of contents)
【原文詳細目次】
Molecular Diagnostics Market by Product & Service(Reagents, Kits, PoC & Tabletop Instruments), Application(COVID-19, Hepatitis, HAI, HIV, Oncology, Genetic Tests), Technology (PCR, NGS, ISH), End User (Hospitals, Diagnostic Labs)-Global Forecast to 2026
Table of Contents
1.... INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
・ FIGURE 1....................................... INCLUSIONS & EXCLUSIONS
1.2.1 MARKETS COVERED.. 35
・ FIGURE 2............................. MOLECULAR DIAGNOSTICS MARKET
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
・ FIGURE 3.. MOLECULAR DIAGNOSTICS MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 PRIMARY DATA
2.2.2.1 KEY DATA FROM PRIMARY SOURCES
2.2.2.2 KEY INDUSTRY INSIGHTS
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
・ FIGURE 5............ MOLECULAR DIAGNOSTICS MARKET: BOTTOM-UP APPROACH
・ FIGURE 6................. CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH.. 45
・ FIGURE 7............. MOLECULAR DIAGNOSTICS MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 8.......................... DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19 HEALTH ASSESSMENT
2.7 COVID-19 ECONOMIC ASSESSMENT
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
・ FIGURE 9................. CRITERIA IMPACTING THE GLOBAL ECONOMY
・ FIGURE 10........... RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN
THE MOLECULAR DIAGNOSTICS MARKET
3.... EXECUTIVE SUMMARY
・ FIGURE 11...... MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION)
・ FIGURE 12............... MOLECULAR DIAGNOSTICS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)
・ FIGURE 13... MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION)
・ FIGURE 14.... MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)
・ FIGURE 15........ MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)
・ FIGURE 16........... MOLECULAR DIAGNOSTICS MARKET, BY REGION,
2021 VS. 2026 (USD MILLION)
4.... PREMIUM INSIGHTS
4.1 MOLECULAR DIAGNOSTICS MARKET OVERVIEW... 56
・ FIGURE 17............. THE RISING ADOPTION OF POC DIAGNOSTICS IS EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD
4.2 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION)
・ FIGURE 18........... THE REAGENTS & KITS SEGMENT IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE MARKET, BY PRODUCT & SERVICE, IN 2021
4.3 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
・ FIGURE 19.. THE PCR SEGMENT IS EXPECTED TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
4.4 MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021 VS. 2026
・ FIGURE 20. THE DIAGNOSTIC LABORATORIES SEGMENT IS EXPECTED TO HOLD THE LARGEST SHARE OF THE END USER MARKET DURING THE FORECAST PERIOD
5.... MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 21............. MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 THE INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER.. 60
5.2.1.2 RISING FOCUS ON R&D AND FUNDING IN MOLECULAR DIAGNOSTICS
5.2.1.3 INCREASING AWARENESS FOR EARLY DISEASE DIAGNOSIS IN DEVELOPING COUNTRIES
5.2.1.4 RISING TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR DIAGNOSTICS
5.2.1.5 INCREASING USE OF POC DIAGNOSTIC TESTS
5.2.2 RESTRAINT
5.2.2.1 UNFAVORABLE REIMBURSEMENT SCENARIO
5.2.2.2 THE HIGH COST OF INSTRUMENTS
5.2.3 OPPORTUNITIES
5.2.3.1 THE GROWING SIGNIFICANCE OF COMPANION DIAGNOSTICS
5.2.3.2 GROWTH OPPORTUNITIES IN EMERGING COUNTRIES
5.2.4 CHALLENGES
5.2.4.1 CHANGING REGULATORY LANDSCAPE
5.2.4.2 OPERATIONAL BARRIERS
5.2.4.3 THE INTRODUCTION OF ALTERNATIVE TECHNOLOGIES
5.2.5 COVID 19 IMPACT ANALYSIS
5.3 PRICING ANALYSIS
・ TABLE 1 PRICING ANALYSIS OF MOLECULAR DIAGNOSTIC PRODUCTS (2021)
5.4 PATENT ANALYSIS
5.5 VALUE CHAIN ANALYSIS
・ FIGURE 22................ VALUE CHAIN ANALYSIS OF THE MOLECULAR DIAGNOSTICS MARKET
5.6 SUPPLY CHAIN ANALYSIS
・ FIGURE 23.......................................... SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
・ FIGURE 24.............................. PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT FROM NEW ENTRANTS
5.8.2 THREAT FROM SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.9 PESTLE ANALYSIS
5.10 REGULATORY LANDSCAPE
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 CANADA
5.10.2 EUROPE
5.10.3 ASIA PACIFIC
5.10.3.1 CHINA
5.10.3.2 JAPAN
5.10.3.3 INDIA
5.10.4 LATIN AMERICA
5.10.4.1 BRAZIL
5.10.4.2 MEXICO
5.10.5 MIDDLE EAST
5.10.6 AFRICA
5.11 TRADE ANALYSIS
5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
5.11.1.1 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016─2020 (USD MILLION)
5.11.1.2 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016─2020 (TONS)
5.12 TECHNOLOGY ANALYSIS
6.... MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
・ TABLE 2.......... MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)
6.2 REAGENTS & KITS
6.2.1 THE RECURRENT PURCHASE OF REAGENTS & KITS IS A MAJOR FACTOR DRIVING MARKET GROWTH
・ TABLE 3... REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 INSTRUMENTS
・ TABLE 4........... INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 5....... INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.1 ・ TABLETOP INSTRUMENTS
6.3.1.1 THE OUTBREAK OF COVID-19 AND RISING INCIDENCES OF CANCER DRIVES THE GROWTH OF THIS SEGMENT
・ TABLE 6. ・ TABLETOP INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 POR・ TABLE & POC INSTRUMENTS
6.3.2.1 THE INCREASING ADOPTION OF POC TECHNOLOGIES DRIVES THE GROWTH OF THIS SEGMENT
・ TABLE 7... POR・ TABLE & POC INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION)
6.4 SERVICES & SOFTWARE
6.4.1 THE GROWING UPTAKE OF ADVANCED INSTRUMENTS IN THE MOLECULAR DIAGNOSTICS MARKET DRIVES SEGMENT GROWTH
・ TABLE 8.. SERVICES & SOFTWARE MARKET, BY REGION, 2019–2026 (USD MILLION)
7.... MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
・ TABLE 9....... MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
7.2 POLYMERASE CHAIN REACTION (PCR)
7.2.1 THE GROWING USE OF PCR IN PROTEOMICS AND GENOMICS IS A MAJOR GROWTH DRIVER FOR THIS SEGMENT
・ TABLE 10 PCR TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
7.3.1 THE COST-BENEFITS OF THIS TECHNOLOGY IS A KEY FACTOR DRIVING THE MARKET GROWTH
・ TABLE 11...... INAAT TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
7.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING
7.4.1 INCREASING USE OF NGS IN THE DIAGNOSIS OF CANCER IS A GROWTH DRIVER FOR THIS SEGMENT
・ TABLE 12........ DNA SEQUENCING & NGS TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION)
7.5 IN SITU HYBRIDIZATION (ISH)
7.5.1 THE RISING PREVALENCE OF CANCER AND GENETIC DISORDERS IS A KEY FACTOR DRIVING SEGMENT GROWTH.. 89
・ TABLE 13. ISH TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
7.6 DNA MICROARRAY
7.6.1 THE INTRODUCTION OF DNA MICROARRAY HAS ACCELERATED GENE EXPRESSION AND DISEASE DIAGNOSIS
・ TABLE 14...... DNA MICROARRAY TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION)
7.7 OTHER TECHNOLOGIES
・ TABLE 15.. OTHER TECHNOLOGIES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.... MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
8.1 INTRODUCTION
・ TABLE 16...... MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
8.2 INFECTIOUS DISEASE DIAGNOSTICS
・ TABLE 17.. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION,
2019–2026 (USD MILLION)
・ TABLE 18...... INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TYPE,
2019–2026 (USD MILLION)
8.2.1 COVID-19
8.2.1.1 THE OUTBREAK OF THE PANDEMIC IS A KEY FACTOR DRIVING MARKET GROWTH
・ TABLE 19 COVID-19 DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 20 COVID-19 DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
8.2.2 HEPATITIS
8.2.2.1 THE GLOBAL PREVALENCE OF HEPATITIS IS A KEY FACTOR DRIVING MARKET GROWTH
・ TABLE 21 HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 22................ HEPATITIS DIAGNOSTICS MARKET, BY REGION,
2019–2026 (MILLION ASSAYS)
8.2.3 CT/NG
8.2.3.1 CT/NG INFECTIONS ARE THE MOST COMMONLY PREVALENT STDS; KEY FACTOR DRIVING THE MARKET GROWTH
・ TABLE 23.... CT/NG DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 24.... CT/NG DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
8.2.4 HIV
8.2.4.1 THE INCREASING NUMBER OF BLOOD TRANSFUSIONS & DONATIONS WILL DRIVE THE MARKET GROWTH FOR THIS SEGMENT
・ TABLE 25. HIV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 26........ HIV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
8.2.5 HAI
8.2.5.1 THE RISING BURDEN OF MRSA INFECTIONS IS A KEY FACTOR DRIVING THE MARKET GROWTH FOR THIS SEGMENT
・ TABLE 27. HAI DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 28........ HAI DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
8.2.6 HPV
8.2.6.1 TECHNOLOGICAL ADVANCEMENTS SUCH AS RAPID HPV DIAGNOSTICS TO DRIVE THE MARKET GROWTH FOR THIS SEGMENT
・ TABLE 29 HPV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 30....... HPV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
8.2.7 TUBERCULOSIS
8.2.7.1 THE INCREASING BURDEN OF TB GLOBALLY TO DRIVE THE MARKET GROWTH OF THIS SEGMENT
・ TABLE 31......... TUBERCULOSIS DIAGNOSTICS MARKET, BY REGION,
2019–2026 (USD MILLION)
・ TABLE 32......... TUBERCULOSIS DIAGNOSTICS MARKET, BY REGION,
2019–2026 (MILLION TESTS)
8.2.8 INFLUENZA
8.2.8.1 THE RISING FOCUS ON CONTAINING THE SPREAD OF INFLUENZA DRIVES THE MARKET GROWTH FOR THIS SEGMENT
・ TABLE 33..... INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 34..... INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
8.2.9 OTHER INFECTIOUS DISEASES
・ TABLE 35......... OTHER INFECTIOUS DISEASES MARKET, BY REGION,
2019–2026 (USD MILLION)
8.3 ONCOLOGY TESTING
・ TABLE 36..... ONCOLOGY TESTING MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 37.. ONCOLOGY TESTING MARKET, BY TYPE, 2019–2026 (USD MILLION)
8.3.1 BREAST CANCER
8.3.1.1 THE INCREASING PREVALENCE OF BREAST CANCER IS A KEY DRIVER FOR MARKET GROWTH
・ TABLE 38..... ONCOLOGY TESTING MARKET FOR BREAST CANCER, BY REGION,
2019–2026 (USD MILLION)
8.3.2 COLORECTAL CANCER.. 106
8.3.2.1 THE RISING FOCUS ON THE DEVELOPMENT OF COMPANION DIAGNOSTIC ASSAYS DRIVES THE MARKET GROWTH
・ TABLE 39.. ONCOLOGY TESTING MARKET FOR COLORECTAL CANCER, BY REGION,
2019–2026 (USD MILLION)
8.3.3 LUNG CANCER
8.3.3.1 INCREASING RESEARCH FOR LUNG CANCER BIOMARKERS TO DRIVE THE MARKET GROWTH
・ TABLE 40........ ONCOLOGY TESTING MARKET FOR LUNG CANCER, BY REGION,
2019–2026 (USD MILLION)
8.3.4 PROSTATE CANCER.. 108
8.3.4.1 ADVANCEMENTS IN GENOMIC TECHNOLOGIES FOR THE DEVELOPMENT OF NEW BIOMARKERS DRIVE THE MARKET GROWTH
・ TABLE 41.. ONCOLOGY TESTING MARKET FOR PROSTATE CANCER, BY REGION,
2019–2026 (USD MILLION)
8.3.5 OTHER CANCERS
・ TABLE 42......... OTHER CANCER DIAGNOSTICS MARKET, BY REGION,
2019–2026 (USD MILLION)
8.4 GENETIC TESTS
8.4.1 GENETIC TESTING ENABLES THE DIAGNOSIS OF VARIOUS DISEASES
・ TABLE 43.... GENETIC TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.5 OTHER APPLICATIONS
・ TABLE 44... OTHER APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
9.... MOLECULAR DIAGNOSTICS MARKET, BY END USER
9.1 INTRODUCTION
・ TABLE 45.......... MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.2 DIAGNOSTIC LABORATORIES
9.2.1 INCREASING OUTSOURCING OF ACTIVITIES TO DIAGNOSTIC LABORATORIES FOR REDUCED COSTS DRIVES MARKET GROWTH
・ TABLE 46...... MOLECULAR DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2019–2026 (USD MILLION)
9.3 HOSPITALS AND CLINICS
9.3.1 THE INCREASING NUMBER OF HOSPITALS WORLDWIDE IS A MAJOR FACTOR DRIVING MARKET GROWTH
・ TABLE 47.. MOLECULAR DIAGNOSTICS MARKET FOR HOSPITALS AND CLINICS,
BY REGION, 2019–2026 (USD MILLION)
9.4 OTHER END USERS
・ TABLE 48........ MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
10.. MOLECULAR DIAGNOSTICS MARKET, BY REGION
10.1 INTRODUCTION
・ TABLE 49............. MOLECULAR DIAGNOSTICS MARKET, BY REGION,
2019–2026 (USD MILLION)
10.2 NORTH AMERICA
・ FIGURE 25.... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT
・ TABLE 50. NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 51..... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 52. NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 53. NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 54. NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 THE INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER IS A KEY FACTOR EXPECTED TO DRIVE MARKET GROWTH IN THE US
・ TABLE 55... US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)
・ TABLE 56 US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 57 US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 58..... US: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 THE AVAILABILITY OF FUNDING FOR GENOMICS RESEARCH IN CANADA DRIVES THE MARKET GROWTH
・ TABLE 59............ CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 60............ CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 61............ CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 62...... CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.3 EUROPE
・ TABLE 63............ EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 64 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 65............ EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 66............ EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 67...... EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE THE MARKET GROWTH IN GERMANY
・ TABLE 68.......... GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 69.......... GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 70.......... GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 71.... GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.3.2 ITALY
10.3.2.1 ADOPTION OF ADVANCED DIAGNOSTIC TECHNOLOGIES TO DRIVE MARKET GROWTH IN ITALY
・ TABLE 72 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)
・ TABLE 73................ ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 74................ ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 75.. ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 RISING R&D EXPENDITURE IN FRANCE TO DRIVE THE MARKET GROWTH
・ TABLE 76 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 77............ FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 78............ FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 79...... FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.3.4 RUSSIA
10.3.4.1 INCREASING ACCESS TO QUALITY HEALTHCARE WILL SUPPORT MARKET GROWTH IN RUSSIA
・ TABLE 80 RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 81............. RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 82............. RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 83....... RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 THE INCREASING DEMAND FOR GENETIC TESTING IS EXPECTED TO DRIVE MARKET GROWTH IN SPAIN
・ TABLE 84. SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 85............... SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
2019–2026 (USD MILLION)
・ TABLE 86............... SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 87 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.3.6 UK
10.3.6.1 THE INCREASING NUMBER OF ACCREDITED DIAGNOSTIC LABORATORIES PROPELS MARKET GROWTH FOR MOLECULAR DIAGNOSTICS IN THE UK
・ TABLE 88... UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)
・ TABLE 89 UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 90 UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 91..... UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.3.7 REST OF EUROPE
・ TABLE 92. ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)
・ TABLE 93................. ROE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 94 ROE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 95... ROE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
・ FIGURE 26.... APAC: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT
・ TABLE 96.. APAC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 97 APAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)
・ TABLE 98................ APAC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 99................ APAC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 100 APAC: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 GROWING PUBLIC ACCESS TO MODERN HEALTHCARE AND THE OUTBREAK OF COVID-19 TO DRIVE MARKET GROWTH
・ TABLE 101 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 102............. CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 103............. CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 104....... CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 UNIVERSAL HEALTHCARE REIMBURSEMENT POLICY TO DRIVE MARKET GROWTH IN JAPAN
・ TABLE 105 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 106............. JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 107............. JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 108....... JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 INCREASING PRIVATE & PUBLIC INVESTMENTS IN THE COUNTRY’S HEALTHCARE SYSTEM WILL DRIVE MARKET GROWTH
・ TABLE 109 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)
・ TABLE 110.............. INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 111.............. INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 112 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 THE PREVALENCE OF INFECTIOUS DISEASES IN AUSTRALIA IS A KEY DRIVER FOR MARKET GROWTH
・ TABLE 113....... AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 114....... AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 115....... AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 116. AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC (ROAPAC)
・ TABLE 117.......... ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 118.......... ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 119.......... ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 120.... ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.5 LATIN AMERICA
・ TABLE 121. LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 122..... LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 123. LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 124. LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 125. LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 IMPROVING HEALTHCARE INFRASTRUCTURE IN BRAZIL TO DRIVE THE GROWTH OF THE MOLECULAR DIAGNOSTICS MARKET
・ TABLE 126............ BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 127............ BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 128............ BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 129...... BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 THE IMPROVING ACCESSIBILITY AND AFFORDABILITY OF HEALTHCARE SERVICES TO DRIVE MARKET GROWTH FOR MOLECULAR DIAGNOSTICS
・ TABLE 130........... MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 131........... MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 132........... MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 133..... MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
・ TABLE 134......... ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・ TABLE 135......... ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 136......... ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 137... ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.6 MIDDLE EAST AND AFRICA
・ TABLE 138 MEA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)
・ TABLE 139............... MEA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 140............... MEA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 141. MEA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.. COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
11.4 MARKET SHARE ANALYSIS
・ FIGURE 28........ MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYERS (2020)
11.4.1 MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY
11.4.1.1 POLYMERASE CHAIN REACTION (PCR)
・ FIGURE 29... GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR PCR, MARKET SHARE ANALYSIS, BY KEY PLAYER (2020)
11.4.1.2 DNA SEQUENCING AND NGS
・ FIGURE 30.... GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, MARKET SHARE ANALYSIS, BY KEY PLAYER (2020)
11.4.1.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
・ TABLE 142. GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY KEY PLAYERS, 2020
11.4.1.4 IN SITU HYBRIDIZATION (ISH)
・ TABLE 143. GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR ISH, BY KEY PLAYERS, 2020
11.4.2 MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY APPLICATION
11.4.2.1 INFECTIOUS DISEASE APPLICATIONS
・ TABLE 144..... GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RANKING,
BY KEY PLAYERS, 2020
11.5 COMPETITIVE LEADERSHIP MAPPING
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
・ FIGURE 31........ MOLECULAR DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
11.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/ SME (2020)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS.. 169
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES.. 169
・ FIGURE 32........ MOLECULAR DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/ SME, 2019.. 170
11.7 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF TOP PLAYERS
・ FIGURE 33. PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE MOLECULAR DIAGNOSTICS MARKET
11.8 COMPETITIVE SCENARIO.. 171
・ FIGURE 34................... MARKET EVALUATION MATRIX, 2018-2020
11.8.1 MOLECULAR DIAGNOSTICS: PRODUCT LAUNCHES AND REGULATORY APPROVALS (JANUARY 2018 – MARCH 2021)
・ TABLE 145 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
11.8.2 MOLECULAR DIAGNOSTICS: DEALS (JANUARY 2018 – MARCH 2021)
・ TABLE 146............................................................ KEY DEALS
11.8.3 MOLECULAR DIAGNOSTICS: OTHER DEVELOPMENTS (JANUARY 2018 – MARCH 2021)
・ TABLE 147...................................... OTHER KEY DEVELOPMENTS
12.. COMPANY PROFILES
12.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, RIGHT TO WIN)*
12.1.1 F. HOFFMANN-LA ROCHE LTD.
・ TABLE 148...... F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
・ FIGURE 35...... F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
12.1.2 HOLOGIC, INC.
・ TABLE 149.......................... HOLOGIC, INC.: BUSINESS OVERVIEW
・ FIGURE 36............... HOLOGIC, INC.: COMPANY SNAPSHOT (2020)
12.1.3 BIOMÉRIEUX SA
・ TABLE 150........................ BIOMÉRIEUX SA: BUSINESS OVERVIEW
・ FIGURE 37.............. BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020)
12.1.4 ABBOTT LABORATORIES
・ TABLE 151.............. ABBOTT LABORATORIES: BUSINESS OVERVIEW
・ FIGURE 38.... ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
12.1.5 QIAGEN
・ TABLE 152................................... QIAGEN: BUSINESS OVERVIEW
・ FIGURE 39.................. QIAGEN N.V.: COMPANY SNAPSHOT (2020)
12.1.6 THERMO FISHER SCIENTIFIC INC.
・ TABLE 153.. THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
・ FIGURE 40. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
12.1.7 ILLUMINA, INC.
・ TABLE 154......................... ILLUMINA, INC.: BUSINESS OVERVIEW
・ FIGURE 41............... ILLUMINA, INC.: COMPANY SNAPSHOT (2020)
12.1.8 MYRIAD GENETICS INC.
・ TABLE 155............... MYRIAD GENETICS INC.: BUSINESS OVERVIEW
・ FIGURE 42.... MYRIAD GENETICS INC.: COMPANY SNAPSHOT (2019)
12.1.9 SIEMENS HEALTHINEERS AG
・ TABLE 156........ SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
・ FIGURE 43.. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
12.1.10 DANAHER CORPORATION
・ TABLE 157............ DANAHER CORPORATION: BUSINESS OVERVIEW
・ FIGURE 44.. DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
12.1.11 GRIFOLS S.A.
・ TABLE 158............................ GRIFOLS S.A.: BUSINESS OVERVIEW
・ FIGURE 45.................. GRIFOLS S.A: COMPANY SNAPSHOT (2020)
12.1.12 AGILENT TECHNOLOGIES INC.
・ TABLE 159....... AGILENT TECHNOLOGIES INC.: BUSINESS OVERVIEW
・ FIGURE 46...... AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2020)
12.1.13 BECTON, DICKINSON AND COMPANY
・ TABLE 160............ BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
・ FIGURE 47............ BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
12.1.14 DIASORIN S.P.A
・ TABLE 161........................ DIASORIN S.P.A: BUSINESS OVERVIEW
・ FIGURE 48.............. DIASORIN S.P.A: COMPANY SNAPSHOT (2019)
12.2 START UP/ SME PLAYERS
12.2.1 QUIDEL CORPORATION
・ TABLE 162............... QUIDEL CORPORATION: BUSINESS OVERVIEW
・ FIGURE 49..... QUIDEL CORPORATION: COMPANY SNAPSHOT (2019)
12.2.2 GENETIC SIGNATURES
・ TABLE 163................ GENETIC SIGNATURES: BUSINESS OVERVIEW
・ FIGURE 50...... GENETIC SIGNATURES: COMPANY SNAPSHOT (2020)
12.2.3 MDX HEALTH
・ TABLE 164............................ MDX HEALTH: BUSINESS OVERVIEW
・ FIGURE 51.................. MDX HEALTH: COMPANY SNAPSHOT (2019)
12.2.4 EXACT SCIENCES
・ TABLE 165....................... EXACT SCIENCES: BUSINESS OVERVIEW
・ FIGURE 52............ EXACT SCIENCES: COMPANY SNAPSHOT (2019)
12.2.5 BIOCARTIS NV
・ TABLE 166.......................... BIOCARTIS NV: BUSINESS OVERVIEW
・ FIGURE 53................ BIOCARTIS NV: COMPANY SNAPSHOT (2019)
12.2.6 TBG DIAGNOSTICS LTD.
・ TABLE 167............... TBG DIAGNOSTICS LTD.: BUSINESS OVERVIEW
・ FIGURE 54.... TBG DIAGNOSTICS LTD.: COMPANY SNAPSHOT (2019)
12.2.7 GENMARK DIAGNOSTICS INC.
・ TABLE 168...... GENMARK DIAGNOSTICS INC.: BUSINESS OVERVIEW
・ FIGURE 55...... GENMARK DIAGNOSTICS INC.: COMPANY SNAPSHOT (2019)
12.2.8 LUMINEX CORPORATION
・ TABLE 169............. LUMINEX CORPORATION: BUSINESS OVERVIEW
・ FIGURE 56... LUMINEX CORPORATION: COMPANY SNAPSHOT (2019)
12.2.9 HTG MOLECULAR DIAGNOSTICS
・ TABLE 170.... HTG MOLECULAR DIAGNOSTICS: BUSINESS OVERVIEW
・ FIGURE 57... HTG MOLECULAR DIAGNOSTICS: COMPANY SNAPSHOT (2019)
12.2.10 VELA DIAGNOSTICS
・ TABLE 171.................... VELA DIAGNOSTICS: BUSINESS OVERVIEW
12.2.11 AMOY DIAGNOSTICS CO. LTD.
・ TABLE 172....... AMOY DIAGNOSTICS CO. LTD.: BUSINESS OVERVIEW
12.2.12 MOLBIO DIAGNOSTICS PVT. LTD. 255
・ TABLE 173... MOLBIO DIAGNOSTICS PVT. LTD.: BUSINESS OVERVIEW
12.2.13 ELITECHGROUP
・ TABLE 174........................ ELITECHGROUP: BUSINESS OVERVIEW
12.2.14 SAVYON DIAGNOSTICS LTD.
・ TABLE 175......... SAVYON DIAGNOSTICS LTD.: BUSINESS OVERVIEW
12.2.15 ABACUS DIAGNOSTICA OY
・ TABLE 176........... ABACUS DIAGNOSTICS OY: BUSINESS OVERVIEW
12.2.16 GENEOMBIO TECHNOLOGIES PVT LTD.
・ TABLE 177......... GENEOMBIO TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, RIGHT TO WIN MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13.. APPENDIX
掲載企業リスト
プレスリリース
プレスリリース
当レポートのプレスリリースは発行されておりません。
リサーチカテゴリ一覧
スマートグリッド
お問合わせはこちらから
